• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    More On CHGCF

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Chugai Pharmaceutical Co. Ltd. (CHGCF)

    -Other OTC
    29.35 0.00(0.00%) Feb 4
    Add to Portfolio
    Prev Close:29.35
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:29.35 - 29.35
    52wk Range:26.00 - 29.35
    Volume:0
    Avg Vol (3m):2
    Market Cap:N/A
    P/E (ttm):37.92
    EPS (ttm):0.77
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    • No Headlines available for CHGCF at this time.

    Key Statistics

    Forward P/E (1 yr):0.24
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :108.47
    Quarterly EPS Est (Mar-15) :27.50
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Chugai Pharmaceutical Co., Ltd. manufactures, sells, imports, and exports pharmaceutical products in Japan and internationally. Its products in oncology include Avastin, Herceptin, Rituxan, Xeloda, Tarceva, Neutrogin, Perjeta, Kadcyla, and Alecens... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback